AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egelhoff, J. C.
Right arrow Articles by Cohen, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egelhoff, J. C.
Right arrow Articles by Cohen, B. H.

American Journal of Neuroradiology, Vol 13, Issue 4 1071-1077, Copyright © 1992 by American Society of Neuroradiology


ARTICLES

Spinal MR findings in neurofibromatosis types 1 and 2

JC Egelhoff, DJ Bates, JS Ross, AD Rothner and BH Cohen
Department of Radiology, Cleveland Clinic Foundation, OH 44195.

PURPOSE: To evaluate the frequency and nature of spinal pathology, the frequency of clinically silent lesions, and the potential benefit of screening spinal MR in neurofibromatosis patients. PATIENTS AND METHODS: 28 neurofibromatosis type-1 (NF-1) patients and nine neurofibromatosis type-2 (NF-2) patients were studied with postcontrast spinal MR imaging. RESULTS: NF-1: One patient had a biopsy-proven low- grade glioma; five patients, intradural, extramedullary masses (N = 23); one patient, extradural masses (N = 2) (neurofibromas); 16 patients had bony abnormalities; and three patients thecal sac abnormalities. NF-2: Five patients demonstrated intramedullary masses (five/eight ependymomas); nine patients, intradural, extramedullary masses (meningiomas, schwannomas); and four patients, bony abnormalities. Eight/10 NF-1 and four/nine NF-2 patients had asymptomatic masses. CONCLUSION: Intradural disease is common, often asymptomatic, and often presents at a young age in NF-1 and NF-2 patients. Because of the propensity to develop significant asymptomatic as well as symptomatic intradural disease, screening of the entire spine with MR is recommended in both NF-1 and NF-2 patients.


This article has been cited by other articles:


Home page
BrainHome page
A. Drouet, P. Wolkenstein, J.-P. Lefaucheur, S. Pinson, P. Combemale, R. K. Gherardi, P. Brugieres, J. Salama, P. Ehre, P. Decq, et al.
Neurofibromatosis 1-associated neuropathies: a reappraisal
Brain, September 1, 2004; 127(9): 1993 - 2009.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H Kehrer-Sawatzki, S Tinschert, and D E Jenne
Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region
J. Med. Genet., October 1, 2003; 40(10): e116 - 116.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
L Messiaen, V Riccardi, J Peltonen, O Maertens, T Callens, S L Karvonen, E-L Leisti, J Koivunen, I Vandenbroucke, K Stephens, et al.
Independent NF1 mutations in two large families with spinal neurofibromatosis
J. Med. Genet., February 1, 2003; 40(2): 122 - 126.
[Full Text] [PDF]


Home page
RadiologyHome page
N. J. Patronas, N. Courcoutsakis, C. M. Bromley, G. L. Katzman, M. MacCollin, and D. M. Parry
Intramedullary and Spinal Canal Tumors in Patients with Neurofibromatosis 2: MR Imaging Findings and Correlation with Genotype
Radiology, February 1, 2001; 218(2): 434 - 442.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
J. L. Rutkowski, K. Wu, D. H. Gutmann, P. J. Boyer, and E. Legius
Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1
Hum. Mol. Genet., April 12, 2000; 9(7): 1059 - 1066.
[Abstract] [Full Text] [PDF]